UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 248

Sortiert nach

Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody

Cancer treatment reviews, 2019-06, Vol.76, p.57-67

2019

Link zum Volltext

Verfügbarkeit prüfen

Prediction of an Imminent Fracture After an Index Fracture – Models Derived From the Frisbee Cohort

Journal of bone and mineral research, 2022-01, Vol.37 (1), p.59-67

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Calcified Tissue International, 2016, Vol.98 (1), p.1-17

2016

Link zum Volltext

Verfügbarkeit prüfen

Postfracture Risk Assessment: Target the Centrally Sited Fractures First! A Substudy of NoFRACT

Journal of bone and mineral research, 2020-04, Vol.35 (4), p.827-828

2020

Link zum Volltext

Verfügbarkeit prüfen

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

The journal of clinical endocrinology and metabolism, 2022-04, Vol.107 (5), p.1441-1460

2022

Link zum Volltext

Verfügbarkeit prüfen

Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia

Journal of internal medicine, 2023-03, Vol.293 (3), p.309-328

2023

Link zum Volltext

Verfügbarkeit prüfen

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Journal of clinical oncology, 2010-12, Vol.28 (35), p.5132-5139

2010

Link zum Volltext

Verfügbarkeit prüfen

Assessment of bone quality with trabecular bone score in type 2 diabetes mellitus: A study from the FRISBEE cohort

International journal of clinical practice (Esher), 2019-05, Vol.73 (5), p.e13347-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Increased fracture rate in women with breast cancer: a review of the hidden risk

BMC cancer, 2011-08, Vol.11 (1), p.384-384, Article 384

Body, Jean-Jacques

2011

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases

Calcified tissue international, 2022-10, Vol.111 (4), p.367-379

2022

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates

Journal of clinical oncology, 2009-04, Vol.27 (10), p.1564-1571

2009

Link zum Volltext

Verfügbarkeit prüfen

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review

Supportive care in cancer, 2019-02, Vol.27 (2), p.383-394

2019

Link zum Volltext

Verfügbarkeit prüfen

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club

Frontiers in endocrinology (Lausanne), 2022-06, Vol.13, p.908727-908727

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure

Journal of bone and mineral research, 2010-03, Vol.25 (3), p.440-446

2010

Link zum Volltext

Verfügbarkeit prüfen

Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

Journal of bone oncology, 2021-06, Vol.28, p.100355-100355, Article 100355

2021

Link zum Volltext

Verfügbarkeit prüfen

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

Journal of clinical oncology, 2007-10, Vol.25 (28), p.4431-4437

2007

Link zum Volltext

Verfügbarkeit prüfen

Patient preferences for treatments to delay bone metastases

The Prostate, 2014-11, Vol.74 (15), p.1488-1497

2014

Link zum Volltext

Verfügbarkeit prüfen

Independent External Validation of FRAX and Garvan Fracture Risk Calculators: A Sub‐Study of the FRISBEE Cohort

JBMR plus, 2021-09, Vol.5 (9), p.e10532-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe

Journal of bone oncology, 2019-02, Vol.14, p.100212, Article 100212

2019

Link zum Volltext

Verfügbarkeit prüfen

A Phase I study of AMGN‐0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

Cancer, 2003-02, Vol.97 (S3), p.887-892

2003

Link zum Volltext

Verfügbarkeit prüfen

Fibroblast growth factor 23 and its role in phosphate homeostasis

European journal of endocrinology, 2010-01, Vol.162 (1), p.1

2010

Link zum Volltext

Verfügbarkeit prüfen

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion

BMC urology, 2018-09, Vol.18 (1), p.81-11, Article 81

2018

Link zum Volltext

Verfügbarkeit prüfen

Bisphosphonates for malignancy-related bone disease: current status, future developments

Supportive care in cancer, 2006-05, Vol.14 (5), p.408-418

Body, Jean-Jacques

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 248

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(231)
Mit Volltextzugriff
(228)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(163)
Science & Technology
(163)
Humans
(147)
Female
(94)
Oncology
(81)
Biological And Medical Sciences
(66)
Medical Sciences
(60)
Bone Neoplasms - Secondary
(59)
Middle Aged
(59)
Endocrinology & Metabolism
(53)
Aged
(50)
Male
(50)
Diphosphonates - Therapeutic Use
(49)
Bone Neoplasms - Drug Therapy
(40)
Adult
(39)
Breast Neoplasms - Pathology
(37)
Breast Cancer
(36)
Osteoporosis
(36)
Bone Metastases
(35)
Bone Density Conservation Agents - Therapeutic Use
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody

Prediction of an Imminent Fracture After an Index Fracture – Models Derived From the Frisbee Cohort

Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Postfracture Risk Assessment: Target the Centrally Sited Fractures First! A Substudy of NoFRACT

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

Assessment of bone quality with trabecular bone score in type 2 diabetes mellitus: A study from the FRISBEE cohort

Increased fracture rate in women with breast cancer: a review of the hidden risk

Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases

Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club

Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases: Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid

Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG

Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure

Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

Patient preferences for treatments to delay bone metastases

Independent External Validation of FRAX and Garvan Fracture Risk Calculators: A Sub‐Study of the FRISBEE Cohort

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe

A Phase I study of AMGN‐0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

Fibroblast growth factor 23 and its role in phosphate homeostasis

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion

Bisphosphonates for malignancy-related bone disease: current status, future developments

Suchergebnisse filtern